Well, it is from the First report of the Monitor that says in the Conclusions section 5.4:
"Based on the comparable recent fermentation based transactions adjusted for scale, Nexant estimate the value of the Sarnia plant as an operating facility to be within the range of CAD$70-95 million."
Granted that was from 5-22-2018, but I'm sure many others would be interested in picking up just the Sarnia plant alone for more the $4.anything million.
Looks like a comparable sale to Iogen in 2013 included more than just tangible assets, but included all commercial rights to Iogen Bio-Products' existing product portfolio, pipeline, facilities and know-how for $80 million as one of 5 comparables in the last 5 years.
As wording in these documents does say for all US based assets and Canadian, the verbiage is different in multiple places.
I'm in it till the end even though this wording seems to be misconstrued by many, or everyone is looking at different areas of the same document that appear to contradict our understanding.
Still $4.3 mil just doesn't make sense. Even if they needed to put $30 million into the plant to fix it up that is still a killer deal!
Furthermore, the Second report of the Monitor shows with the Cash, Inventory, Plant and equipment, Accounts receivable, and estimated realization fees the Market Value of Sarina inc is $74,631,000 CAD but has an orderly liquidation value of $30,131,000 as of June 8, 2018... would they then settle for only $4.3 mil?
